This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Legacy software systems no longer make sense for life sciences businesses, especially those in Pharmaceutical manufacturing. The problem is that complexity, regulation, and competition have changed how pharmaceutical and life sciences firms must do business. Other benefits include: 1.
The pharmaceutical industry has been transformed in recent years by pressure from intensely competitive markets and the need to comply with new regulations that mandate the highest quality standards across all processes. As such, cloud ERP is critical for pharmaceutical operations today given this environment.
Without the robust pharmaceutical sector, many people throughout the world would have been wiped out long ago by even mild illnesses. But ongoing technological advancements like cloud computing and SAP solutions for life sciences have enabled pharmaceutical companies to withstand most of these challenges.
Drawing on our work with global companies across manufacturing, automotive, pharmaceuticals, semiconductors, software, technology, financial services, and a range of service industries, we outline the key strategic and tactical actions companies are taking to navigate this period of heightened uncertainty.
Consumer health and safety is the fundamental responsibility of a pharmaceutical company. To avoid this, the pharmaceutical supply chain is one of the most heavily regulated supply chains in the world. A major threat to the industry’s credibility is the rampant circulation of counterfeit products.
Serialization in pharmaceutical packaging is the process of assigning and labeling a unique serial number for each product to be sold. This contains information about the product’s origin, batch number, and validity or expiration date.
The flow of processes and operations in a pharmaceutical company is extremely complex and labor-intensive, owing to stringent production regulations and competitive market demands.
As a pharmaceutical company, you’ll face numerous business challenges, most of which require specialized attention and full integration of critical systems and operations.
But what exactly are the steps of quality control in the pharmaceutical industry? These changes require companies to implement life science ERP software to centralize, streamline, and optimize their processes.
The pharmaceutical industry has undergone significant evolution within the past 15 years. Recently, biopharmaceutical companies have become increasingly reliant on outsourced contract services for various elements of their value chain.
Tying the prices it charges for medicines to those charged by pharmaceutical companies will put the healthcare giant’s pharmacy business on a more sustainable footing, executives said.
It’s an uphill task for Contract Development and Manufacturer Organizations (CDMOs) to ensure product quality at the rapid pace demanded by customers, especially when they must deal with safety, control, and regulatory regimes in fields such as pharmaceuticals, biotech, and other areas of the life sciences.
They’re outsourced to handle drug and therapy development as well as to manufacture pharmaceutical, nutraceutical, and biological materials. Contract development and manufacturing organizations (CDMOs) face unique challenges. And beyond that, they are often a key part of research and development prior to manufacturing as well.
Quality plays a pivotal role in the success of any business. Delays in delivery are often caused by products not meeting the mandated quality standards. Failure to meet quality standards can have grave implications on the production environment and the company's public image.
When a life sciences product deviates from specs, be it a pharmaceutical or medical device, public health is affected and the defect might not even be readily observable. When a pen is manufactured incorrectly or suffers from shoddy inputs, a consumer just pulls out a different pen.
Life sciences businesses such as pharmaceutical makers and medical device manufacturers not only benefit from GMP adherence but they also are required to follow it according to FDA regulations. The processes that life sciences businesses follow must be validated in line with FDA regulations 21 CFR.
One industry that is slowly adopting cloud computing technology is the pharmaceutical sector. The uptake of this technology in the pharmaceutical industry remains somewhat measured due to strict protocols and compliance regulations.
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Pharmaceutical Market Study – 2022”. Based on available data from European pharmaceutical providers, the FCF Pharmaceutical Market Study is a detailed and comprehensive.
For your pharmaceutical company to thrive in the current unstable market, you need to adopt new and advanced technologies that will streamline your daily operations. One of the latest technologies that you should have in your pharmaceutical company is an enterprise resource planning (ERP) system.
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Pharmaceutical Market Study – 2021”. Based on available data from European pharmaceutical providers, the FCF Pharmaceutical Market Study is a detailed and comprehensive.
Pharmaceutical commercialization is the goal of every drug development process. After a new medicine is created, it needs to be mass-produced and distributed to the market, from individual consumers to pharmaceutical providers.
percent from Q4 2019 to Q4 2020, as consumer health and pharmaceutical sales rose while medical devices worldwide operational sales fell amid the pandemic. It reported that pharmaceutical worldwide operational sales grew by 8.4 Johnson & Johnson reported on Tuesday (Jan.
As the world continues to advance, conclusive life science explorations and tests have become extremely necessary to help medical professionals and pharmaceutical companies develop medical products and solutions that are more effective, reliable, and sustainable.
” Eli Lilly — Shares of the pharmaceutical company slumped more than 1% in premarket after the U.S. Regeneron Pharmaceuticals — The pharmaceutical giant gained 1% in the premarket after being upgraded to overweight from neutral by JPMorgan. The firm also announced that co-CEO Reed Hastings would step down from the role.
billion it raised in a secondary offering on the Hong Kong stock exchange to expand its eCommerce pharmaceutical business as it rides a wave of growth amid the coronavirus. Alibaba Health Information Technology plans to pump the $1.3
The pharmaceutical industry is one of the most heavily regulated industries due to the implications product quality has on public health. Automation and optimization of key processes such as manufacturing, supply chain, etc., help companies enhance their productivity while maintaining high-quality standards.
ENTOD Pharmaceuticals has appointed Balasubramanian K Pillai as its new CFO. Pillai, a Chartered Accountant with over 26 years of diverse experience, aims to enhance financial strategies and drive sustainable growth.
"We are in the process of identifying seven centres of excellence (CoE) which will undertake research in moonshot areas," N Yuvaraj, joint secretary, department of pharmaceuticals, to ET.
Contract research organizations (CROs) provide essential support to pharmaceutical, biotech, and medical device manufacturers across a range of projects. Solutions such as SAP ERP for life sciences can be valuable resources for both the CRO and their client, streamlining contractual research projects of a technical and confidential nature.
Life science companies, such as those related to medical devices and pharmaceuticals, can greatly benefit from an enterprise resource planning (ERP) solution. Implementing an ERP system can be a drawn out and complex process, however. In this article, we'll discuss the major steps involved in ERP implementation so you know what to expect.
In recent years, the life sciences industry has grown extremely robust, attracting many players across various sectors, such as pharmaceutical and medical device manufacturing, and biotechnology.
As an owner of a pharmaceutical company, you need an enterprise resource planning (ERP) system that will help you to streamline your daily operations. This system will also help you to keep all your products and production processes compliant with the relevant safety regulations.
Modern biotechnology has enabled individuals and companies in the pharmaceutical industry to create breakthrough products and equipment for combating devastating and uncommon diseases, reducing environmental footprints, feeding hungry populations, and promoting safer, cleaner, and effective industrial processes.
Kala Pharmaceuticals — The biopharmaceutical company surged more than 200% following the Food and Drug Administration’s acceptance of an investigational new drug application for its potential treatment for persistent corneal epithelial defect. The firm gave the stock a price target of $29, which presents an upside of 75.4%
Next, Dev Ahuja , CFO of Novelis , explains how his pharmaceutical background at Novartis fueled disciplined resource allocation and strategic growth in manufacturing. On this episode of 1-2-3 , Emma Seymour , CFO at Deputy, reveals the behind-the-scenes steps to raising capital from strategic partners and achieving unicorn status.
Mankind Pharma, Dr Reddy's Laboratories, and Torrent Pharma are interested in acquiring JB Chemicals & Pharmaceuticals from KKR. KKR's investment arm, TAU Investment, owns 53.78% in JB Chemicals, worth Rs 14,020 crore. The company's revenue doubled to Rs 3,484 crore in FY24 under KKR's ownership.
The DEA said in December that it wouldn’t allow any increase in 2023 production of pharmaceutical ingredients that go into Adderall and other stimulants used to treat ADHD. While the letter doesn’t cite specific companies, it reflects the DEA’s concerns about marketing efforts for ADHD treatment by telehealth companies such as Cerebral Inc.
Pharmaceuticals supply chain security expert Amy Shortman reportedly told the Financial Times: “There will always be a market for people who wouldn't necessarily have access to that medicine and wanted to protect themselves and their families. There will be, certainly globally, a lot of money that can be made by criminals.”.
North American industries most affected by currency exposure were professional services, biotech and pharmaceuticals, machinery, trading and distribution, chemicals and health equipment and supplies.
GSK — Shares of the pharmaceutical company dropped 6.2% Ralph Lauren — The clothing maker popped 7.7% after it reported better-than-expected second quarter earnings. UBS called the company a “turnaround stock,” noting useful changes to its business model.
HIG ), and Regeneron Pharmaceuticals, Inc. The plan will hand control of the specialty pharmaceutical company to creditors. Among companies reporting earnings today are Bristol Myers Squibb Company ( BMY ), Cboe Global Markets, Inc. CBOE ), The Hartford Financial Services Group, Inc. ( Bureau of Labor Statistics. billion opioid deal.
We organize all of the trending information in your field so you don't have to. Join 39,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content